Financial statements Biomat
Balance sheet data of BIOMAT
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 11 907 773,32 | 10 910 227,89 | 10 109 918,68 |
| A. Fixed assets | 704 152,32 | 508 569,67 | 403 849,30 |
| B. Current assets | 11 203 621,00 | 10 401 658,22 | 9 706 069,38 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 11 907 773,32 | 10 910 227,89 | 10 109 918,68 |
| A. Equity | 9 153 459,53 | 8 110 919,27 | 7 992 147,51 |
| B. Liabilities and provisions for liabilities | 2 754 313,79 | 2 799 308,62 | 2 117 771,17 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.